Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-02

Clinical Trial Update: Oral Supplementation During PR Participation in COPD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on oral supplementation during participation in pulmonary rehabilitation for COPD is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Copd | Phase 2 | Status: UNKNOWN